- SPAG1 promotes the development of AML by activating the ERK/MAPK sign…
Number of the records: 1  

SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax

  1. SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax / Lu Liu ... [et al.]. Neoplasma Vol. 69, no. 5 (2022), s. 1108-1118
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.